Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.

Abstract

Cytochrome P450 2J2 plays a significant role in the epoxidation of arachidonic acid to signaling molecules important in cardiovascular events. CYP2J2 also contributes to drug metabolism and is responsible for the intestinal clearance of ebastine. However, the interaction between arachidonic acid metabolism and drug metabolism in cardiac tissue, the main expression site of CYP2J2, has not been examined. Here we investigate an adult-derived human primary cardiac cell line as a suitable model to study metabolic drug interactions (inhibition and induction) of CYP2J2 in cardiac tissue. The primary human cardiomyocyte cell line demonstrated similar mRNA-expression profiles of P450 enzymes to adult human ventricular tissue. CYP2J2 was the dominant isozyme with minor contributions from CYP2D6 and CYP2E1. Both terfenadine and astemizole oxidation were observed in this cell line, whereas midazolam was not metabolized suggesting lack of CYP3A activity. Compared with recombinant CYP2J2, terfenadine was hydroxylated in cardiomyocytes at a similar K(m) value of 1.5 μM. The V(max) of terfenadine hydroxylation in recombinant enzyme was found to be 29.4 pmol/pmol P450 per minute and in the cells 6.0 pmol/pmol P450 per minute. CYP2J2 activity in the cell line was inhibited by danazol, astemizole, and ketoconazole in submicromolar range, but also by xenobiotics known to cause cardiac adverse effects. Of the 14 compounds tested for CYP2J2 induction, only rosiglitazone increased mRNA expression, by 1.8-fold. This cell model can be a useful in vitro model to investigate the role of CYP2J2-mediated drug metabolism, arachidonic acid metabolism, and their association to drug induced cardiotoxicity.

• Authors: Eric A Evangelista, Rüdiger Kaspera, Nahush A Mokadam, J P Jones 3rd, Rheem A Totah
• Journal: Drug metabolism and disposition: the biological fate of chemicals (Drug Metab Dispos) Vol. 41 Issue 12 Pg. 2087-94 (Dec 2013) ISSN: 1521-009X [Electronic] United States
• PMID: 24021950 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)

Chemical References

• CYP2J2 protein, human
• Cytochrome P-450 Enzyme Inhibitors
• Enzyme Inhibitors
• Hormones
• RNA, Messenger
• Xenobiotics
• Cytochrome P-450 Enzyme System
• Cytochrome P-450 CYP2J2

Topics

• Cells, Cultured
• Cytochrome P-450 CYP2J2
• Cytochrome P-450 Enzyme Inhibitors
• Cytochrome P-450 Enzyme System (genetics, metabolism)
• Drug Interactions (genetics)
• Enzyme Inhibitors (pharmacology)
• Female
• Hormones (metabolism)
• Humans
• Kinetics
• Male
• Myocytes, Cardiac (drug effects, enzymology, metabolism)
• RNA, Messenger (genetics)
• Xenobiotics (pharmacology)